Daniela Priscila Marchi-Salvador

Prof. Dr. Daniela Priscila Marchi-Salvador

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 September 2013 in BioMed Research International
Verified
Journal Article
Open access
PDF file
BCBruna Mara Aparecida De Carvalho
Bruna Mara Aparecida De Carvalho
JSJ. D. L. Santos
J. D. L. Santos
BXB. M. Xavier
B. M. Xavier
José Rafael de AlmeidaJosé Rafael de Almeida
José Rafael de Almeida
LRL. M. Resende
L. M. Resende
DMDaniela Priscila Marchi-Salvador
Daniela Priscila Marchi-Salvador
Ophidian envenomation is an important health problem in Brazil and other South American countries. In folk medicine, especially in developing countries, several vegetal species are employed for the treatment of snakebites in communities that lack prompt access to serum therapy. However, the identification and characterization of the effects of several new plants or their isolated compounds, which are able to inhibit the activities of snake venom, are extremely important and such studies are imperative. Snake venom contains several organic and inorganic compounds; phospholipases A2(PLA2s) are one of the principal toxic components of venom. PLA2s display a wide variety of pharmacological activities, such as neurotoxicity, myotoxicity, cardiotoxicity, anticoagulant, hemorrhagic, and edema-inducing effects. PLA2inhibition is of pharmacological and therapeutic interests as these enzymes are involved in several inflammatory diseases. This review describes the results of several studies of plant extracts and their isolated active principles, when used against crude snake venoms or their toxic fractions. Isolated inhibitors, such as steroids, terpenoids, and phenolic compounds, are able to inhibit PLA2s from different snake venoms. The design of specific inhibitors of PLA2s might help in the development of new pharmaceutical drugs, more specific antivenom, or even as alternative approaches for treating snakebites.

1 June 2019 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
ISIvancia D.L. Sousa
Ivancia D.L. Sousa
ABAyrton R. Barbosa
Ayrton R. Barbosa
GSGuilherme Henrique Marchi Salvador
Guilherme Henrique Marchi Salvador
BFBreno E.F. Frihling
Breno E.F. Frihling
PSPaula H. Santa-Rita
Paula H. Santa-Rita
DMDaniela Priscila Marchi-Salvador
Daniela Priscila Marchi-Salvador

24 July 2022 in Molecules
Verified
Journal Article
Open access
PDF file
KMKyle Mamounis
Kyle Mamounis
MNMaria Luiza Caldas Nogueira
Maria Luiza Caldas Nogueira
DMDaniela Priscila Marchi-Salvador
Daniela Priscila Marchi-Salvador
AVAndrés Andreo Vidal
Andrés Andreo Vidal
ASAntonio Sanchez-Amat
Antonio Sanchez-Amat
VDVictor Davidson
Victor Davidson
The Pseudoalteromonas luteoviolacea strain CPMOR-1 expresses a flavin adenine dinucleotide (FAD)-dependent L-amino acid oxidase (LAAO) with broad substrate specificity. Steady-state kinetic analysis of its reactivity towards the 20 proteinogenic amino acids showed some activity to all except proline. The relative specific activity for amino acid substrates was not correlated only with Km or kcat values, since the two parameters often varied independently of each other. Variation in Km was attributed to the differential binding affinity. Variation in kcat was attributed to differential positioning of the bound substrate relative to FAD that decreased the reaction rate. A structural model of this LAAO was compared with structures of other FAD-dependent LAAOs that have different substrate specificities: an LAAO from snake venom that prefers aromatic amino acid substrates and a fungal LAAO that is specific for lysine. While the amino acid sequences of these LAAOs are not very similar, their overall structures are comparable. The differential activity towards specific amino acids was correlated with specific residues in the active sites of these LAAOs. Residues in the active site that interact with the amino and carboxyl groups attached to the α-carbon of the substrate amino acid are conserved in all of the LAAOs. Residues that interact with the side chains of the amino acid substrates show variation. This provides insight into the structural determinants of the LAAOs that dictate their different substrate preferences. These results are of interest for harnessing these enzymes for possible applications in biotechnology, such as deracemization.

1 January 2020 in Journal of Medical Cases
Verified
Journal Article
Open access
PDF file
POPierri E.A. Oliveira
Pierri E.A. Oliveira
GSGuilherme H.M. Salvador
Guilherme H.M. Salvador
DMDaniela Priscila Marchi-Salvador
Daniela Priscila Marchi-Salvador
Malignant hyperthermia (MH) is an acute pharmacogenetic disorder, which while uncommon is potentially fatal. MH is a calcium channelopathy of skeletal muscle in which a constant increase of intracytoplasmic Ca2+ concentration occurs causing a change in cellular metabolism. A hypermetabolic state develops when susceptible patients are exposed to halogenated volatile inhalational anesthetic agents and depolarizing muscle relaxants and/or extreme physical activity in hot environments. MH presents variable clinical expression. During an episode of MH, the patient may present clinical signs and laboratory findings including masseter muscle spasm, tachycardia, rise in end-tidal CO2 (EtCO2), tachypnea, hyperthermia, cyanosis, metabolic acidosis, rhabdomyolysis, hyperkalemia, myoglobinuria, hyperlactacidemia, and acute renal failure. The aim of this case report is to describe an episode of MH associated with the use of halogenated anesthetic during bariatric surgery. A 29-year-old Brazilian man was admitted to the hospital to undergo a bariatric surgery. The patient’s relevant medical history included morbid obesity grade III, allergy to sulfa-based drugs and severe obstructive sleep apnea. Preoperative evaluations with cardiopulmonary exercise testing, echocardiogram and electrocardiogram showed no anatomical and functional changes of the patient’s heart. Surgical procedures lasted for 4 h, without complications, but the evolution of the patient’s condition indicated oliguria and acute breathing insufficiency. Five hours after the patient was placed under mechanical ventilation in the intensive care unit, he started to present clinical signs of hypermetabolic state, with tremors, excessive sweating, and rapid body temperature increases. In the postoperative period, the patient had hyperglycemia, hypocalcemia, hypernatremia, hyperkalemia, changes in creatine phosphokinase (CPK), aspartate transaminase (AST), alanine aminotransferase (ALT), urea and creatine concentrations, and metabolic and respiratory acidosis. Urinalysis showed traces of proteinuria, presence of ketones, leukocytes, red blood cells, and urobilinogen. In our case report, MH crisis was diagnosed late; the dantrolene was not administrated because it was not available and the patient died. This detailed case report of MH episode triggered by isoflurane anesthetic during bariatric surgery allowed us to describe the severity and lethality of this hypermetabolic syndrome. Dantrolene should be mandatory in all operating rooms. Knowledge of the symptoms, an early diagnosis and an adequate treatment can prevent the death of patients in MH crisis.J Med Cases. 2020;11(12):379-387doi: https://doi.org/10.14740/jmc3577

1 January 2026 in Brazilian Journal of Biology
Verified
Journal Article
Open access
POP. E. A. Oliveira
P. E. A. Oliveira
DSD. P. Silva
D. P. Silva
SFS. S. Ferreira
S. S. Ferreira
DMDaniela Priscila Marchi-Salvador
Daniela Priscila Marchi-Salvador
AFA. A. Oliveira Filho
A. A. Oliveira Filho
Introduction Since antiquity, natural products have been widely used to relieve symptoms and prevent numerous diseases. Early treatments for vascular disorders, including thrombosis, relied heavily on plant-derived substances, which later served as prototypes for the development of platelet aggregation inhibitors and coagulation-modulating agents. Among these bioactive constituents, phenolic compounds—abundantly found in various botanical sources—have gained prominence due to their well-established antioxidant properties and reported anticoagulant effects. Recent studies highlight that the structural diversity of phenolic acids, particularly cinnamic acid (CA) and its derivatives, offers a valuable chemical scaffold for developing new therapeutic agents targeting thrombogenesis and oxidative imbalance. Objective This study aimed to evaluate, in vitro, the pharmacological (anticoagulant and antioxidant) and toxicological (oxidant and cytotoxic) activities of cinnamic acid (CA) and five synthetic derivatives—4HDCN, 4MTCN, 3,4DHCN, 3,4DMCN, and 3H4MCN. Methods Anticoagulant activity was assessed using a semi-automated coagulometer by measuring clotting time after exposure of human plasma to each molecule. Antioxidant, oxidant, and cytotoxic (hemolytic) activities were determined using human erythrocytes from blood groups A, B, and O. Oxidative and antioxidant responses were quantified by spectrophotometry following exposure to phenylhydrazine as a pro-oxidant inducer. Hemolysis was evaluated at concentrations ranging from 0 to 400 mg/dL. Results In the anticoagulant assays, the derivative 3,4DHCN exhibited the strongest activity, prolonging clotting time to 176.6 s, slightly surpassing 3,4MTCN (165.6 s). All molecules demonstrated low or negligible oxidizing activity (<7.1%). Regarding antioxidant potential, 4MTCN showed the most effective protection against phenylhydrazine-induced oxidation, reducing oxidative damage to 8.7%. None of the tested compounds induced moderate or high hemolysis at concentrations up to 200 mg/dL. However, at 400 mg/dL, CA and 4HDCN produced high hemolytic rates across erythrocyte types. In type A cells, hemolysis reached 89.4% (CA) and 76.0% (4HDCN); in type B, 64.3% and 60.5%; and in type O, 90.1% and 70.7%, respectively. Conclusion Dihydroxylated and dimethoxylated cinnamic acid derivatives demonstrated notable anticoagulant activity, minimal oxidative effects, low antioxidant capacity, and an absence of cytotoxicity in human erythrocytes at therapeutically relevant concentrations. These findings indicate that such molecules represent promising candidates for the development of new anticoagulant agents with favorable safety profiles.

8 September 2023 in Venoms and Toxins
Verified
Journal Article
Closed access
PDF file
LSLayssa Gualberto da Silva
Layssa Gualberto da Silva
POPierri Emanoel De Abreu Oliveira
Pierri Emanoel De Abreu Oliveira
PSPedro Gabriel Nascimento dos Santos
Pedro Gabriel Nascimento dos Santos
JSJuliana Alves Costa Ribeiro Souza
Juliana Alves Costa Ribeiro Souza
RMRafael Xavier Martins
Rafael Xavier Martins
DMDaniela Priscila Marchi-Salvador
Daniela Priscila Marchi-Salvador
Introduction: Approximately 90% of reported and identified cases of snakebites in Brazil are caused by species belonging to the Bothrops genus. These snakes have clinical rele-vance due to their venom composition, which contains substances capable of triggering local and systemic effects, leading to morbidities and/or mortality. Objective: The objective of this study was to evaluate the toxic and toxinological effects of Both-rops Jararacussu snake venom on zebrafish embryos and larvae. Methods: The stability of B. Jararacussu snake venom under the conditions used in the toxicity experiments in zebrafish embryos and larvae was evaluated on citrated human plasma. Zebrafish embryos and/or larvae mortality, morphological alterations, spontaneous tail movements and heartbeat caused by the venom were quantified within 96 hours. Toxicity parameters and activity of enzyme-related toxicity biomarkers were evaluated in zebrafish after 96 hours of semi-static exposure to the venom. Results: The results indicated that the venom causes toxicity in zebrafish embryos and larvae, in-ducing embryonic mortality, alteration in the number of spontaneous tail movements and activity of biomarker enzymes. The results suggested that the toxic effects caused by the venom in the ear-ly stages of zebrafish development are mediated, in part, by neurotoxic action, induction of oxida-tive and metabolic stress caused by low molecular weight components, and proteins present in this venom. Conclusion: Toxinological evaluations using the zebrafish as a model are scarce; however, this study presented promising results that encourage the development of future research in toxinology using this animal as a model organism.